Five things for pharma marketers to know
COVID-19 deaths surpassed 3 million on Tuesday, with worldwide fatality rates rising yet again. The number of cases has also been increasing as part of what health officials consider a fourth surge. (Reuters)
Hospitalizations among older people have decreased as more have received vaccinations, according to Centers for Disease Control and Prevention director Dr. Rochelle Walensky. Some 75% of Americans aged 65 and older have received at least one shot. (CNBC Weekly)
Mineralys Therapeutics has generated $40 million in Series A funding to study Mitsubishi Tanabe’s selective aldosterone synthase inhibitor. The company plans to develop it into a hypertension therapy. (Endpoints News)
Medical device companies made $904 million in incentive payments to physicians between 2014 and 2017, according to a new study. The sum surpassed payments made by the pharma industry by more than $80 million. (STAT)
Former Obama administration official Gayle Smith has been chosen to lead global vaccine diplomacy efforts. Smith will officially serve as coordinator for global COVID-19 response and health security. (Politico)
The post Five things for pharma marketers to know: Wednesday, April 7, 2021 appeared first on MM+M – Medical Marketing and Media.
